Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports


The Bug Resistant Medicines Market is all set to be in the driver’s seat shortly. Technology adoption once looked upon as a costly endeavor, is slated to witness a drastic transformation in the form of granular applications. Technologies like DevOps and AIOps are constructively disrupting the healthcare IT sector and are expected to create wonders in this regard in the upcoming period.

Market Overview

Bug-resistant medicines are the drugs which are used to stop the infection that is caused by the germs or the bugs i.e. antimicrobials in many cases. There are several drugs which are approved by food and drug administration recently like Ceftolozane/tazobactam, Sivextro, Zerbaxa among others that fight against these kinds of bugs (bacterial strains).

To remain ‘ahead’ of your competitors, request for a sample @

When bugs resist several varieties of the antibiotics, then they are known as superbugs. According to the Centers for Disease Control and Prevention (CDC), Antibiotic-Resistant Superbug is becoming an emerging threat to all the people across the world.

Thus, Bug-resistant medicines are introduced in this way to the Bug-resistant medicines market. Increase in such kind of infection increases the demand of the bug resistant disease. Around 70% of the bugs that cause such kind of infections are resistant to at least one of the antibiotics generally needed to treat them. 490 000 people developed multi-drug resistant Tuberculosis across the world, and drug resistance is outset to impede the fight against deadly diseases such as HIV and malaria in 2016.

As per the Centers for Disease Control and Prevention (CDC), drug-resistant infections reported for around 2 million infections with antimicrobial-resistant bacteria that leads to approximately 23,000 deaths in the United States of America annually. Increasing the prevalence of chronic diseases across the globe drives the Bug-resistant medicines market.

Manufacturers are focusing on the research and development of such type of drugs which helps the patient to recover at the earliest. These bugs can spread mostly from patients in hospitals. Some of the applications that bug-resistant medicines offers include oncology, immunology, neurology, cardiology, respiratory, infectious diseases and others.

Other factors such as the increased burden of genetic diseases such as diabetes among others are expected to boost the growth of the bug-resistant medicines market. The mutation occurs in the microbial strains causes its behavior negative to these medicines.

Pre-Book Right Now for Exclusive Analyst Support @


Market Segmentation

basis of drugs
  • Antiviral
  • Antifungal
  • Antibacterial
  • Others
basis of distribution channel
  • Hospitals
  • Clinics
  • Ambulatory Care Center
  • Others
  • North America
  • Latin America
  • Europe
  • Asia Pacific excluding China
  • China
  • Middle East & Africa

The global Bug-Resistant Medicines market is expected to grow with a moderately increasing CAGR due to the increasing adoption and demand for Bug-Resistant Medicines. Based on the Drugs, it is observed that Antibacterial is done at most of the cases. It is analyzed that, On the basis of end users, hospital segment will hold the maximum market revenue share in the global Bug-Resistant Medicines market over the forecast period. One of the most common uses of Bug-Resistant Medicines is to control the effect of bugs i.e. infection

On the basis of geography, the global Bug-Resistant Medicines market is segmented into six key regions viz. North America, Latin America, Europe, the Asia Pacific excluding China, China, and the Middle East & Africa. The North America Bug-Resistant Medicines market is expected to contribute maximum market share in the global Bug-Resistant Medicines market which is followed by Europe Bug-Resistant Medicines market.

The Asia Pacific Bug-Resistant Medicines market is expected to grow with a maximum CAGR over the forecast period due to less awareness among the people while the Latin America Bug-Resistant Medicines market and the Middle East and Africa concerned market is expected to show steady growth rate over the forecast period. It is estimated that the Middle East and Africa concerned market is to be dominated by South Africa.

Some of the key players present in the global concerned market are F. Hoffmann-La Roche Ltd, Sanofi, Novartis International AG, Pfizer Inc. AbbVie Inc. Gilead, Amgen Inc., GlaxoSmithKline plc. Johnson & Johnson Services, Inc. among others.

Get a Customized Scope to Match Your Need Ask an Expert-


The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Historical Actual Market Size, 2013 – 2017
  • Size & Forecast 2017 to 2026
  • Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Market Drivers and Restraints

Market Research Methodology – Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Report Highlights:

To receive an extensive list of important regions, ask for a Table of Content

About Us: – Persistence Market Research

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales –
Website –



Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts